Detalhe da pesquisa
1.
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
BMJ Open
; 14(3): e077613, 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503417